| pubmed-article:16899628 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:16899628 | lifeskim:mentions | umls-concept:C1704242 | lld:lifeskim |
| pubmed-article:16899628 | lifeskim:mentions | umls-concept:C1274040 | lld:lifeskim |
| pubmed-article:16899628 | lifeskim:mentions | umls-concept:C1280500 | lld:lifeskim |
| pubmed-article:16899628 | lifeskim:mentions | umls-concept:C0334037 | lld:lifeskim |
| pubmed-article:16899628 | lifeskim:mentions | umls-concept:C0762662 | lld:lifeskim |
| pubmed-article:16899628 | lifeskim:mentions | umls-concept:C0282440 | lld:lifeskim |
| pubmed-article:16899628 | lifeskim:mentions | umls-concept:C1096777 | lld:lifeskim |
| pubmed-article:16899628 | lifeskim:mentions | umls-concept:C0443252 | lld:lifeskim |
| pubmed-article:16899628 | pubmed:issue | 15 | lld:pubmed |
| pubmed-article:16899628 | pubmed:dateCreated | 2006-8-10 | lld:pubmed |
| pubmed-article:16899628 | pubmed:abstractText | Gastric cancer and its premalignant gastric lesion, intestinal metaplasia (IM), frequently express cyclooxygenase-2 (COX-2) at high levels. We tested whether long-term use of specific COX-2 inhibitors regress gastric IM. | lld:pubmed |
| pubmed-article:16899628 | pubmed:language | eng | lld:pubmed |
| pubmed-article:16899628 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16899628 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:16899628 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16899628 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16899628 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16899628 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16899628 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16899628 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:16899628 | pubmed:month | Aug | lld:pubmed |
| pubmed-article:16899628 | pubmed:issn | 1078-0432 | lld:pubmed |
| pubmed-article:16899628 | pubmed:author | pubmed-author:SungJoseph... | lld:pubmed |
| pubmed-article:16899628 | pubmed:author | pubmed-author:ChanFrancis... | lld:pubmed |
| pubmed-article:16899628 | pubmed:author | pubmed-author:LeungWai KWK | lld:pubmed |
| pubmed-article:16899628 | pubmed:author | pubmed-author:NgEnders K... | lld:pubmed |
| pubmed-article:16899628 | pubmed:author | pubmed-author:LauJames Y... | lld:pubmed |
| pubmed-article:16899628 | pubmed:author | pubmed-author:ChanWing YWY | lld:pubmed |
| pubmed-article:16899628 | pubmed:author | pubmed-author:AuyeungAlex... | lld:pubmed |
| pubmed-article:16899628 | pubmed:author | pubmed-author:LamCandice... | lld:pubmed |
| pubmed-article:16899628 | pubmed:author | pubmed-author:ChanKui-fatKF | lld:pubmed |
| pubmed-article:16899628 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:16899628 | pubmed:day | 1 | lld:pubmed |
| pubmed-article:16899628 | pubmed:volume | 12 | lld:pubmed |
| pubmed-article:16899628 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:16899628 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:16899628 | pubmed:pagination | 4766-72 | lld:pubmed |
| pubmed-article:16899628 | pubmed:meshHeading | pubmed-meshheading:16899628... | lld:pubmed |
| pubmed-article:16899628 | pubmed:meshHeading | pubmed-meshheading:16899628... | lld:pubmed |
| pubmed-article:16899628 | pubmed:meshHeading | pubmed-meshheading:16899628... | lld:pubmed |
| pubmed-article:16899628 | pubmed:meshHeading | pubmed-meshheading:16899628... | lld:pubmed |
| pubmed-article:16899628 | pubmed:meshHeading | pubmed-meshheading:16899628... | lld:pubmed |
| pubmed-article:16899628 | pubmed:meshHeading | pubmed-meshheading:16899628... | lld:pubmed |
| pubmed-article:16899628 | pubmed:meshHeading | pubmed-meshheading:16899628... | lld:pubmed |
| pubmed-article:16899628 | pubmed:meshHeading | pubmed-meshheading:16899628... | lld:pubmed |
| pubmed-article:16899628 | pubmed:meshHeading | pubmed-meshheading:16899628... | lld:pubmed |
| pubmed-article:16899628 | pubmed:meshHeading | pubmed-meshheading:16899628... | lld:pubmed |
| pubmed-article:16899628 | pubmed:meshHeading | pubmed-meshheading:16899628... | lld:pubmed |
| pubmed-article:16899628 | pubmed:meshHeading | pubmed-meshheading:16899628... | lld:pubmed |
| pubmed-article:16899628 | pubmed:meshHeading | pubmed-meshheading:16899628... | lld:pubmed |
| pubmed-article:16899628 | pubmed:meshHeading | pubmed-meshheading:16899628... | lld:pubmed |
| pubmed-article:16899628 | pubmed:meshHeading | pubmed-meshheading:16899628... | lld:pubmed |
| pubmed-article:16899628 | pubmed:meshHeading | pubmed-meshheading:16899628... | lld:pubmed |
| pubmed-article:16899628 | pubmed:year | 2006 | lld:pubmed |
| pubmed-article:16899628 | pubmed:articleTitle | Effects of long-term rofecoxib on gastric intestinal metaplasia: results of a randomized controlled trial. | lld:pubmed |
| pubmed-article:16899628 | pubmed:affiliation | Institute of Digestive Disease, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, Hong Kong. wkleung@cuhk.edu.hk | lld:pubmed |
| pubmed-article:16899628 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:16899628 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
| pubmed-article:16899628 | pubmed:publicationType | Controlled Clinical Trial | lld:pubmed |
| pubmed-article:16899628 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16899628 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16899628 | lld:pubmed |
